Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-02-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.252784899PMID 12576554PMCID PMC149931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Protease Activity in Live Antigen-presenting Cells Shows Regulation of the Phagosomal Proteolytic Contents During Dendritic Cell Activation

  2002cited by this paper
• Microglia as a source and target of cytokines

  2002cited by this paper
• Neurodegeneration in the Niemann-Pick C mouse: glial involvement.

  2002cited by this paper
• Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B

  2002cited by this paper
• Microglia in neurodegeneration: Molecular aspects

  2001cited by this paper
• NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.

  2000cited by this paper
• Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1‐associated dementia

  2000cited by this paper
• The role of complement in Alzheimer's disease pathology.

  2000cited by this paper
• Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

  2000cited by this paper
• Complement C1q Is Dramatically Up-Regulated in Brain Microglia in Response to Transient Global Cerebral Ischemia1 2

  2000cited by this paper
• Reactive microgliosis.

  1999cited by this paper
• Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.

  1999cited by this paper
• A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

  1999cited by this paper
• A role for preadipocytes as macrophage‐like cells

  1999cited by this paper
• Microglia as mediators of inflammatory and degenerative diseases.

  1999cited by this paper
• Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation

  1998cited by this paper
• Murine MPS I: insights into the pathogenesis of Hurler syndrome

  1998cited by this paper
• X‐inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency

  1998cited by this paper
• Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

  1998cited by this paper
• Interferon gamma gene expression in rat central nervous system glial cells.

  1998cited by this paper
• Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.

  1997cited by this paper
• The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.

  1996cited by this paper
• Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.

  1996cited by this paper
• Expression of Rat Cathepsin S in Phagocytic Cells (*)

  1996cited by this paper
• The metabolic and molecular bases of inherited disease, seventh edition—3-volume set: Edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly, and David Valle. New York, McGraw-Hill, 1995, $285.84 (xxxvi + 4605 pages and 93-page index), ISBN 0-07909-826-6

  1995cited by this paper
• Isolation of a novel macrophage-specific gene by differential cDNA analysis.

  1995cited by this paper
• Markers of mouse macrophage development detected by monoclonal antibodies.

  1994cited by this paper
• Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants.

  1994cited by this paper
• Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family.

  1993cited by this paper
• Long-Term Neurological Effects of Bone Marrow Transplantation in a Canine Lysosomal Storage Disease

  1988cited by this paper
• Mouse lysozyme M gene: isolation, characterization, and expression studies.

  1988cited by this paper
• Macrophages in T and B Cell Compartments and Other Tissue Macrophages Recognized by Monoclonal Antibody MOMA‐2

  1987cited by this paper
• Lectin binding by resting and reactive microglia

  1987cited by this paper
• Neurochemical Characterization of Canine α‐L‐Iduronidase Deficiency Disease (Model of Human Mucopolysaccharidosis I)

  1985cited by this paper
• Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B.

  1984cited by this paper
• Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin.

  1982cited by this paper
• NEUROCHEMISTRY OF THE MUCOPOLYSACCHARIDOSES: BRAIN GLYCOSAMINOGLYCANS, LIPIDS AND LYSOSOMAL ENZYMES IN MUCOPOLYSACCHARIDOSIS TYPE III B (α‐N‐ACETYLGLUCOSAMINIDASE DEFICIENCY)

  1978cited by this paper

• Lipid Nanoparticle-Delivered mRNA Therapy Corrects Neonatal Murine MPS I-H

  2026cites this paper
• Alterations in secondary lipids are associated with neuroinflammation in the brain of Neu1-deficient mice

  2026cites this paper
• Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation

  2025cites this paper
• Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model

  2025cites this paper
• Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I

  2025cites this paper
• Identification of a neuron-specific ferroptosis in the neurodegenerative mucopolysaccharidosis III model

  2025cites this paper
• Repeated ablations of mature Tmem10+ oligodendrocytes recapitulates key pathological features of multiple sclerosis with prolonged demyelination

  2025cites this paper
• Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase

  2025cites this paper
• The Neuroimmune Landscape of the Lysosomal Storage Disorder Sanfilippo Syndrome

  2025cites this paper
• Cathepsin B inhibition blocks amyloidogenesis in the mouse models of neurological lysosomal diseases MPS IIIC and sialidosis

  2025cites this paper
• Extracellular vesicles from microglial cells activated by abnormal heparan sulfate oligosaccharides from Sanfilippo patients impair neuronal dendritic arborization

  2024cites this paper
• Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice

  2024cites this paper
• Photobiomodulation in the infrared spectrum reverses the expansion of circulating natural killer cells and brain microglial activation in Sanfilippo mice

  2024cites this paper
• Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA

  2024cites this paper
• Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies.

  2024cites this paper
• Polymer-Based Drug Delivery Systems Under Investigation For Enzyme Replacement And Other Therapies Of Lysosomal Storage Disorders.

  2023cites this paper
• The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis

  2023cites this paper
• Becker Digital

  2023cites this paper
• Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female mice

  2023cites this paper
• Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1/2 study.

  2023cites this paper
• Evaluation of biochemical profile and oxidative damage to lipids and proteins in patients with lysosomal acid lipase deficiency.

  2023cites this paper
• Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB

  2023cites this paper
• CNS Repopulation by Hematopoietic-Derived Microglia-Like Cells Corrects Progranulin deficiency

  2023cites this paper
• Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups

  2023cites this paper
• Innate Immunity in Mucopolysaccharide Diseases

  2022cites this paper
• Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review

  2022cites this paper
• Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system

  2022cites this paper
• The Role of the Lysosomal Cl−/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration

  2022cites this paper
• Neuroimmune dysfunction in frontotemporal dementia: Insights from progranulin and C9orf72 deficiency.

  2022cites this paper
• Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.

  2022cites this paper
• Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease

  2022cites this paper
• Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease

  2022cites this paper
• The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy

  2022cites this paper
• Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome

  2021cites this paper
• The Mucopolysaccharidoses: Prenatal Diagnosis, Neonatal Screening and Emerging Therapies

  2021cites this paper
• Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II

  2021cites this paper
• Complement cascade functions during brain development and neurodegeneration

  2021cites this paper
• Recombinant NAGLU-IGF2 prevents physical and neurological disease and improves survival in Sanfilippo B syndrome

  2021cites this paper
• Age and Sex Differences in Primary Microglia Culture: A Comparative Study.

  2021cites this paper
• Biomechanical and histological characterization of MPS I mice femurs.

  2021cites this paper
• Lysosomal storage diseases. Mucopolysaccharidosis type III, sanfilippo syndrome

  2021cites this paper
• The abnormal accumulation of heparan sulfate in patients with mucopolysaccharidosis prevents the elastolytic activity of cathepsin V.

  2021cites this paper
• Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

  2021cites this paper
• Do cytokines play role in the pathogenesis of mucopolysaccharidosis

  2021cites this paper
• Modulating poststroke inflammatory mechanisms: Novel aspects of mesenchymal stem cells, extracellular vesicles and microglia

  2021cites this paper
• Neuropathology of murine Sanfilippo D syndrome.

  2021cites this paper
• Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes

  2021cites this paper
• In vivo adenine base editing corrects newborn murine model of Hurler syndrome

  2021cites this paper
• Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I)

  2020cites this paper
• Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions

  2020cites this paper
• Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases.

  2020cites this paper
• Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue

  2020cites this paper
• Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10

  2020cites this paper
• GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease

  2020cites this paper
• Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology

  2020cites this paper
• Zebrafish disease model of human RNASET2-deficient cystic leukoencephalopathy displays abnormalities in early microglia

  2020cites this paper
• Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy

  2020cites this paper
• Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I)

  2020cites this paper
• A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I.

  2020cites this paper
• Pathogenesis of Mucopolysaccharidoses, an Update

  2020influential citation
• Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression

  2020cites this paper
• Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease

  2020cites this paper
• Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex

  2020cites this paper
• Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.

  2020cites this paper
• Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases

  2020cites this paper
• Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB

  2020influential citation
• Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain

  2020cites this paper
• Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)

  2019cites this paper
• Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice

  2019cites this paper
• Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.

  2019cites this paper
• Ultrastructural Analyses of Microglial Interactions with Synapses.

  2019cites this paper
• Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses.

  2019cites this paper
• Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes

  2019cites this paper
• Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease

  2019cites this paper
• Targeted enzyme delivery systems in lysosomal disorders: an innovative form of therapy for mucopolysaccharidosis

  2019cites this paper
• Improving diagnosis and treatment outcomes in mucopolysaccharidoses

  2019cites this paper
• Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice

  2019cites this paper
• Stem Cell-Based Therapy for Ischemic Stroke

  2019cites this paper
• Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome*

  2019influential citation
• Predominant role of microglia in brain iron retention in Sanfilippo syndrome, a pediatric neurodegenerative disease

  2018cites this paper
• BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis

  2018cites this paper
• ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome

  2018influential citation
• Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders.

  2018cites this paper
• Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy

  2018cites this paper
• The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation.

  2018cites this paper
• Characterization of a Mucopolysaccharidosis Type I and GalNAc Transferase deficiency double knockout mouse

  2018influential citation
• Neural precursor cells form integrated brain-like tissue when implanted into rat cerebrospinal fluid

  2018cites this paper
• Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice

  2018cites this paper
• Emerging Therapies For the Treatment of Mucopolysaccharidosis Type III

  2018cites this paper
• Sphingolipids and neuronal degeneration in lysosomal storage disorders

  2018cites this paper
• Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis

  2018cites this paper
• Interactions between stress and physical activity on Alzheimer's disease pathology

  2018cites this paper
• Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments

  2018cites this paper
• Brain‐targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms

  2018cites this paper
• Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency

  2018cites this paper
• Mucopolysaccharidosis type III: current clinical trials, challenges and recommendations

  2018cites this paper
• Recent trends in mucopolysaccharidosis research

  2018cites this paper
• Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease

  2017cites this paper
• Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

  2017cites this paper
• Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells

  2017cites this paper